Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Type, Mode of Delivery & End-User The global coronary stents market will witness a robust CAGR of 7.82%, valued at $8.82 billion in 2022, and expected to appreciate and reach $16.14 billion by 2030, confirms Strategic Market Research. The coronary stent is a critical component of the medical device industry that focuses on producing and distributing small, wire mesh tubes called stents. These stents are used to treat coronary artery disease, where the arteries that supply oxygen and nutrients to the heart muscle become blocked or narrowed due to plaque accumulation. This fatty substance builds up on the arterial walls. The World Health Organization (WHO) estimates that ischemic heart disease (which can be treated with coronary stents) is responsible for 7.5 million deaths worldwide each year. When coronary artery disease occurs, blood flow to the heart muscle can become restricted, leading to chest pain, shortage of breath, and, sometimes heart attack. Stents are designed to hold open the narrowed or blocked arteries, restoring blood flow to the heart muscle and reducing the risk of serious cardiac events. Two primary types of coronary stents exist, bare-metal stents (B.M.S.) and drug-eluting stents (D.E.S.). Bare-metal stents are made of metal and provide structural support to the artery but do not release any medication to the surrounding tissue. On the other hand, drug-eluting stents are coated with medication that helps prevent the re-narrowing of the artery, a process called restenosis. The coronary stents market has witnessed significant growth recently due to many factors, including the rising prevalence of cardiovascular disease, an aging population, and the rising adoption of minimally invasive procedures. The market is highly competitive, with several leading players operating in the industry, including Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, and others. Technological advancements in stent design, materials, and coatings have also contributed to the exponential growth of the coronary stent market. For example, developing biodegradable stents that dissolve over time has shown promise in reducing the risk of long-term complications associated with traditional stent placement. However, the market faces challenges such as regulatory approvals, reimbursement policies, and the high cost of stent procedures. The regulatory approval process for new stent designs and materials can be time-consuming and expensive, limiting innovation and product development. Additionally, reimbursement policies and pricing pressures can impact the adoption of stent procedures by healthcare providers and patients. Despite these challenges, the coronary stents market is expected to grow due to the rise in the prevalence of cardiovascular disease and the rising demand for minimally invasive procedures. Ongoing research and development in stent technology and continued innovation in the field are likely to drive further growth and advancements in the market. High Incidence of Obesity and Diabetes: Obesity and diabetes are two major risk factors for developing cardiovascular disease. As per a report by the Centers for Disease Control and Prevention (C.D.C.), In the U.S.A., obesity was 42.4% among adults. As the global incidence of these conditions continues to rise, so does the demand for stent placement procedures. Obesity and diabetes can cause plaque buildup in the arteries, and other cardiovascular diseases. This plaque buildup can eventually lead to heart attacks and other serious complications, which may require stent placement procedures. Therefore, the high incidence of obesity and diabetes drives demand for coronary stents. Increasing Healthcare Expenditure: The rise in spending on healthcare is driving demand for coronary stents. According to the U.S. Department of the Centers for Medicare & Medicaid Services, U.S. healthcare spending grew 2.7 percent in 2021, reaching USD $4.3 trillion or $12,914 per person. As healthcare spending continues to rise, more patients can access stent placement procedures, driving the market growth. Additionally, favorable reimbursement policies from governments and private insurance companies are increasing access to stent placement procedures, further driving demand. The growing demand for healthcare services in general, including cardiovascular disease treatment, is also contributing to the growth of the coronary stent market. Increasing Awareness and Screening Programs: The growing awareness of cardiovascular disease and the importance of preventative care drive demand for stent placement procedures. The U.S.A. Preventive Services Task Force recommended that all adults between the ages of 40 and 75, who are at increased risk of cardiovascular disease, be screened for high cholesterol and blood pressure. Screening programs and educational initiatives are helping to find out people who are at risk of developing heart disease, which is driving demand for stent placement procedures. Advancements in Imaging Technologies: Advancements in imaging technologies, such as computed tomography (C.T.) and magnetic resonance imaging (M.R.I.), are driving market growth. These imaging technologies enable healthcare providers to diagnose cardiovascular disease more accurately and at a much early stage, leading to increased demand for stent placement procedures. Additionally, these imaging technologies are used to guide stent placement procedures, improving the accuracy of stent placement and reducing complications. Favorable Reimbursement Policies: Favorable reimbursement policies for stent placement procedures in many global regions drive market growth. As per a study done by the American College of Cardiology, the proportion of patients receiving percutaneous coronary intervention (PCI) in the United States with private insurance coverage increased from 31.7% to 46.2% from 2009 to 2016. These policies make it easier for patients to access stent placement procedures and help to increase the adoption of stent placement as a treatment option. In countries like the U.S.A., reimbursement policies are based on the performance of the stent and can encourage the use of newer, more advanced stent designs. Restraints: High Cost of Procedures: One of the biggest restraints facing the coronary stent market is the high cost of stent placement procedures. These procedures can be expensive, especially in countries with limited healthcare budgets, which can limit patient access to stent placement as a treatment option. Additionally, the high cost of procedures can pressure healthcare providers and payers to restrict access to certain types of stents or limit the number of procedures performed. Regulatory Approvals: Regulatory approvals and compliance can also be a restraint on the coronary stent market. Stents are medical devices that are subject to rigorous regulatory scrutiny in most countries. Obtaining regulatory approvals can be time-consuming and expensive, and regulation changes can impact the market dynamics for stent manufacturers. Additionally, regulations may differ between countries, which can limit the ability of manufacturers to expand into new markets. Limited Reimbursement: While favorable reimbursement policies drive the growth of the coronary stents market, limited reimbursement for certain procedures or types of stents can also be a restraint. In some cases, reimbursement policies may be limited to certain patient populations or may only cover a portion of the cost of the procedure. This can make it challenging for patients to access stent placement as a treatment option, especially in countries with limited healthcare budgets. Potential for Complications: While stent placement is generally considered a safe treatment option for coronary artery disease, there is always a risk of complication associated with any medical procedure. Some potential complications associated with stent placement include restenosis (re-narrowing of the artery), stent thrombosis (clotting within the stent), and bleeding. While these complications are relatively rare, they can lead to serious health outcomes and may impact the adoption of stent placement as a treatment option. Additionally, the risk of complications may make some patients hesitant to undergo stent placement, even if their healthcare provider recommends it. Opportunities: Partnerships and Collaborations: Collaboration and partnerships between stent manufacturers and healthcare providers present an opportunity for manufacturers to develop products that are better tailored to the needs of patients. By working closely with healthcare providers, manufacturers can better understand patients' needs and develop products optimized for specific patient population. Additionally, collaborations may help to reduce the cost of stent placement procedures, making them more accessible to patients in need. Personalized Medicine: The rise of personalized medicine offers opportunities for stent manufacturers to develop products tailored to individual patient needs. A recent report by the Tufts Center for the Study of Drug Development notes that personalized medicines comprise 12-50% of company pharmaceutical companies' pipelines. For example, advances in genetic testing may allow healthcare providers to find out patients at higher risk of developing cardiovascular disease and may allow for the development of stents specifically designed for these patients. Additionally, the use of artificial intelligence and machine learning may allow for more accurate predictions of patient outcomes, which can help guide treatment decisions and improve patient outcomes. Growing Medical Tourism: The growing trend of medical tourism in the coronary stents market presents an opportunity for manufacturers and healthcare providers to tap into a new customer base. In 2019, 47% of American adults had traveled abroad for medical treatment, and the top destinations for American medical tourists were Canada, Mexico, Brazil, China, Singapore, and India, as reported by the U.S.A National Library of Medicine. Patients are increasingly seeking medical care, including stent placement procedures, in other countries due to lower costs or better quality of care. This presents an opportunity for companies to expand their market presence and increase market demand for coronary stents. Adoption of Drug-Eluting Stents: Drug-eluting stents (D.E.S.) are coated with medications that prevent the growth of scar tissue and reduce the risk of restenosis. The U.S.A. National Institutes of Health (N.I.H.) states that D.E.S. has been found to reduce the risk of restenosis (the re-narrowing of the artery) by 50% compared to bare-metal stents. The adoption of D.E.S. presents an opportunity for manufacturers to develop more effective stents with better outcomes than bare-metal stents. Additionally, the increasing use of D.E.S. is driving market growth and presents an opportunity for manufacturers to capture market share. Coronary Stents Market Analysis Of Different Segments Covered in the Report By Product Type: Dual Therapy Stents Radioactive Stents Thrombectomy Stents Covered Stents Bioresorbable Stents Biodegradable Stents Hybrid Stents Drug-Eluting Stents Bare Metal Stents By Endovascular Application: Coronary Artery Disease Peripheral Artery Disease Renal Artery Stenosis Others By Endovascular Material: Nitinol Stainless Steel Cobalt-Chromium Alloy Others By Coating: Polymer-based Coated Stents Non-polymer Coated Stents Carbon-based Coated Stents Titanium-nitride Oxide Coated Stents Silicon-carbide Coated Stents By Mode of Delivery: Balloon-Expandable Stents Stent Grafts Transcatheter Aortic Valve Replacement (TAVR) Stents Embolic Protection Stents Self-Expandable Stents By Technology: Laser Cutting 3D-Printed Stents Microfabrication Nanotechnology-based Stents Electropolishing Others By End-User: Hospitals Diagnostic Centers Academic and Research Institutes Ambulatory Surgery Centers Cardiology Center. Regional Coverage Analysis North America US Canada Mexico Rest of North America Europe Germany France U.K Netherlands Switzerland Finland Belgium Russia Italy Spain Turkey Rest of Europe Asia Pacific China Japan India South Korea Singapore Malaysia Australia Thailand Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Segments Analysis & Insights By Product Type, Drug-Eluting Stents are the dominant product type, with a market share of approximately 70%. DES are coated with medication to help prevent restenosis (re-narrowing of the artery after treatment). Bare metal stents do not have this coating and are used less frequently than drug-eluting stents. Bare Metal Stents hold a market share of approximately 20%. Bioresorbable stents are made of materials that gradually dissolve and are absorbed by the body over time. Bioresorbable Stents, Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Biodegradable Stents, and Hybrid Stents collectively hold a market share of approximately 10%. By Endovascular Application, Coronary Artery Disease is the dominant endovascular application, with a market share of approximately 70%. Coronary artery disease refers to clogged coronary arteries that supply blood to the heart. Peripheral Artery Disease, Renal Artery Stenosis, and Others collectively hold a market share of approximately 30%. Peripheral artery disease refers to blockages in other body parts, such as the legs. Renal artery stenosis refers to blockages in the arteries that supply blood to the kidneys. By Endovascular Material, Nitinol is the dominant material, with a market share of approximately 40%. Nitinol is a type of shape-memory alloy commonly used in stents because of its flexibility and ability to come back to its original shape after being bent. Stainless steel and cobalt-chromium alloy are also frequently used in stents. Stainless Steel holds a market share of approximately 30%. Cobalt-Chromium Alloy holds a market share of approximately 25%. Others collectively hold a market share of approximately 5%. By Coating, The coating on a stent can help reduce the risk of restenosis. Polymer-based coatings are the most common type of coating, but non-polymer coatings are also used. Carbon-based, titanium-nitride oxide and silicon-carbide coatings are newer types of coatings that are being researched. Polymer-based Coated Stents are the dominant coating, with a market share of approximately 65%. Non-polymer Coated Stents hold a market share of approximately 25%. Carbon-based Coated Stents, Titanium-nitride Oxide Coated Stents, and Silicon-carbide Coated Stents collectively hold a market share of approximately 10%. By Mode of Delivery, Balloon-Expandable Stents are the dominant mode of delivery, with a market share of approximately 40%. Balloon-expandable stents are placed in the artery using an inflated balloon to expand the stent. Self-expandable stents expand on their own once they are placed in the artery. Self-Expandable Stents hold a market share of approximately 35%. Transcatheter aortic valve replacement (TAVR) stents replace a damaged heart valve without the need for open heart surgery. Transcatheter Aortic Valve Replacement (TAVR) Stents, Stent Grafts, and Embolic Protection Stents collectively hold a market share of approximately 25%. By Technology, Laser Cutting is the dominant technology, with a market share of approximately 45%. Laser cutting is used to precisely cut the stent material into the desired shape. Microfabrication involves using advanced manufacturing techniques to create small, precise features on the stent surface. Microfabrication holds a market share of approximately 30%. 3D-Printed Stents, Nanotechnology-based Stents, Electropolishing, and Others collectively hold a market share of approximately 25%. 3D-printed stents are made using 3D printing technology. Nanotechnology-based stents use tiny particles to help prevent restenosis. Electropolishing is a process that smoothens the surface of the stent. By End-User, Hospitals are the primary location for stent procedures and are the dominant end-users with a market share of approximately 45%, but other facilities, such as ambulatory surgery centers and cardiology centers, also perform these procedures. Academic and research institutes may be involved in developing new stent technologies or conducting clinical trials. Ambulatory Surgery Centers hold a market share of approximately 20%. Cardiology Centers, Diagnostic Centers, and Academic and Research Institutes collectively hold a market share of approximately 35%. By Region, North America and Europe have historically been the largest markets for stents. Still, the Asia-Pacific region is experiencing significant growth due to an increasing prevalence of the cardiovascular disease. The Department of National Health Service (N.H.S.) in the United Kingdom reports that approximately 70,000 coronary stent procedures are performed annually in England. Latin America and, the Middle East & Africa are smaller markets for stents but are expected to grow in the coming years. North America is the dominant region, with a market share of approximately 35%. Europe holds a market share of roughly 30%. Asia Pacific holds a market share of 15%. Latin America, and Middle East & Africa collectively hold a market share of approximately 20%. Coronary Stents Market Report Coverage Report Attributes Details Forecast Period 2023-2030 Base Year for Estimation 2022 Historical Data 2017-2021 Market Size Value in 2022 USD 8.84 billion Revenue Forecast in 2030 USD 16.14 billion Growth Rate (CAGR 2023-2030) 7.82% Segmentation By Product Type, Endovascular Application, Endovascular Material, Coating, Mode of Delivery, Technology, End-User, Region By Product Type Dual Therapy Stents Radioactive Stents Thrombectomy Stents Covered Stents Bioresorbable Stents Biodegradable Stents Hybrid Stents Drug-Eluting Stents Bare Metal Stents By Endovascular Application Coronary Artery Disease Peripheral Artery Disease Renal Artery Stenosis Others By Endovascular Material Nitinol Stainless Steel Cobalt-Chromium Alloy Others By Coating Polymer-based Coated Stents Non-polymer Coated Stents Carbon-based Coated Stents Titanium-nitride Oxide Coated Stents Silicon-carbide Coated Stents By Mode of Delivery Balloon-Expandable Stents Stent Grafts Transcatheter Aortic Valve Replacement (TAVR) Stents Embolic Protection Stents Self-Expandable Stents By Technology Laser Cutting 3D-Printed Stents Microfabrication Nanotechnology-based Stents Electropolishing Others By End-User Hospitals Diagnostic Centers Academic and Research Institutes Ambulatory Surgery Centers Cardiology Center. By Region North America Europe Asia-Pacific Latin America Middle East & Africa Global Coronary Stents Market Competitive Landscape Analysis The competitive landscape analysis provides adequate details on the major competitors that are prevailing in the market environment. The comparison is performed based on the company overview, the overall potential of the market, investment in R&D, total revenue generated, market initiatives, company financials, strengths and weaknesses, production sites and facilities, production capacity, etc. Abbott Laboratories Boston Scientific Corporation Medtronic plc Terumo Corporation B. Braun Melsungen AG Biosensors International Group, Ltd. BIOTRONIK SE & Co. KG Cook Medical Inc. C. R. Bard, Inc. (now part of B.D.) Endologix Inc. Cordis Corporation (a Cardinal Health company) MicroPort Scientific Corporation W. L. Gore & Associates, Inc. Meril Life Sciences Pvt. Ltd. STENTYS SA In recent years, there has been a key trend towards mergers and acquisitions in the stent market as companies look to expand their product offerings and gain access to new markets. For example, in 2021, Terumo Corporation acquired Quirem Medical, a Dutch company that works on research and development of radioactive microspheres which is used in the treatment of liver cancer. There has also been a significant focus on innovation in the stent market, with companies investing in new technologies and materials to improve the safety and effectiveness of stents. For example, Boston Scientific Corporation has developed a bio-absorbable polymer-based drug-eluting stent designed to dissolve gradually in the body after keeping a blocked artery open. Recent Developments In January 2023, The F.D.A. approved the BioFreedom Drug Coated Coronary Stent System, which is designed to treat coronary artery disease-related constriction of the blood vessels in patients at high risk for bleeding due to certain conditions. The stent is coated with Biolimus A9, which is slowly released to prevent re-narrowing. In a primary clinical study, patients who received the BioFreedom stent were able to discontinue one of their blood-thinning medications after a month without an increase in the risk of death or heart attack. This approval adds to the competitive landscape of the coronary stent market, giving physicians and patients an additional option. In October 2022, Cordis, a leading interventional cardiovascular technology manufacturer, acquired Swiss medical technology company MedAlliance. Cordis will invest $235 million upfront till 2029, with up to $1.135 billion for regulatory and commercial milestones. MedAlliance's SELUTION (Sustained Limus Release) drug-eluting balloon (D.E.B.) product line will expand Cordis' product line, sales, marketing, and distribution. Frequently Asked Question About This Report How big is the coronary stents market? The size of the Coronary Stents market is USD 8.84 bn in 2022 and is expected to reach USD 16.14 bn by 2030. Which segment accounted for the highest market share? The drug-eluting stents segment accounts for the highest market share in the coronary stents market. What are the different key factors that are driving the overall growth of the market? The coronary stents market is experiencing significant growth due to various factors. One of the imperative drivers is the increasing prevalence of cardiovascular diseases, including obesity and diabetes, which have become a global health concern. Additionally, there has been a rise in awareness and screening programs, leading to early detection and treatment of these diseases. Moreover, favorable reimbursement policies and a growing trend of medical tourism have further increased the demand for coronary stents. What is the coronary stents market growth? The CAGR for the Coronary Stents market is 7.82%. Who are the major companies involved in the global market? There are several major companies involved in the global coronary stents market, including Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Biosensors International Group, Ltd., Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical LLC, Cardinal Health, Inc., and Stentys SA, among others. . Table of Contents 1. EXECUTIVE SUMMARY 1.1. Market Attractiveness 1.2. Understanding the Target Customers 1.3. CXO perspective 1.4. Global Coronary Stents Market, Historical Market Size & Future Projections Analysis 1.5. Global Coronary Stents Market, By Product Type 1.6. Global Coronary Stents Market, By Endovascular Application 1.7. Global Coronary Stents Market, By Endovascular Material 1.8. Global Coronary Stents Market, By Coating 1.9. Global Coronary Stents Market, By Mode of Delivery 1.10. Global Coronary Stents Market, By Technology 1.11. Global Coronary Stents Market, By End-User 1.12. Global Coronary Stents Market, By Region 2. MARKET SHARE ANALYSIS 2.1. Top 15 Players with Revenue and Sales Volume 2.2. Market Share, 2022 3. SALES VOLUME (UNITS), NUMBER OF PROCEDURES/NUMBER OF DEPLOYMENTS (UNITS), BY REGION 3.1. North America (United States, Canada) 3.2. Europe (UK, Germany, France, Netherlands, Italy, Spain, Benelux, Rest of Europe) 3.3. Asia Pacific (China, Japan, South Korea, India, Australia, Rest of APAC) 3.4. Latin America 3.5. Middle East and Africa 4. INVESTMENT OPPORTUNITIES IN THE MARKET 4.1. On Going Market Developments 4.2. Merger & Acquisition Trends 4.3. Key Investment Opportunities 4.4. Most Potential Segments from Growth and Investment Perspective 5. MARKET INTRODUCTION 5.1. Definition 5.2. Scope of the Study 5.3. Market Structure 5.4. Macro Factor Indicator Analysis 5.5. Key findings 5.5.1. Top investment pockets 6. RESEARCH METHODOLOGY 6.1. Research Process 6.2. Primary Research 6.3. Secondary Research 6.4. Market Size Estimation 6.5. Forecast Model 7. MARKET DYNAMICS 7.1. Introduction 7.2. Drivers 7.3. Restraints 7.4. Opportunities 7.5. Challenges 7.6. Covid 19 Impact Analysis 8. GLOBAL CORONARY STENTS MARKET ANALYSIS BY SEGMENT (REGION LEVEL ANALYSIS) 8.1. Overview 8.2. Global Coronary Stents Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 8.3. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030) 8.4. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 8.4.1. Dual Therapy Stents 8.4.2. Radioactive Stents 8.4.3. Thrombectomy Stents 8.4.4. Covered Stents 8.4.5. Bioresorbable Stents 8.4.6. Biodegradable Stents 8.4.7. Hybrid Stents 8.4.8. Drug-Eluting Stents 8.4.9. Bare Metal Stents 8.4.10. Other Devices 8.5. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 8.5.1. Coronary Artery Disease 8.5.2. Peripheral Artery Disease 8.5.3. Renal Artery Stenosis 8.5.4. Others 8.6. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 8.6.1. Nitinol 8.6.2. Stainless Steel 8.6.3. Cobalt-Chromium Alloy 8.6.4. Others 8.7. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 8.7.1. Polymer-based Coated Stents 8.7.2. Non-polymer Coated Stents 8.7.3. Carbon-based Coated Stents 8.7.4. Titanium-nitride Oxide Coated Stents 8.7.5. Silicon-carbide Coated Stents 8.8. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 8.8.1. Balloon-Expandable Stents 8.8.2. Stent Grafts 8.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 8.8.4. Embolic Protection Stents 8.8.5. Self-Expandable Stents 8.9. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 8.9.1. Laser Cutting 8.9.2. 3D-Printed Stents 8.9.3. Microfabrication 8.9.4. Nanotechnology-based Stents 8.9.5. Electropolishing 8.9.6. Others 8.10. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 8.10.1. Hospitals 8.10.2. Diagnostic Centers 8.10.3. Ambulatory Surgical Centers 8.10.4. Academic and Research Institutes 8.10.5. Cardiology Center 8.11. Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Geography 8.11.1. North America 8.11.2. Asia Pacific 8.11.3. Europe 8.11.4. Latin America 8.11.5. Middle East and Africa 9. NORTH AMERICA CORONARY STENTS MARKET ANALYSIS 9.1. Overview 9.2. North America Coronary Stents Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 9.3. North America Coronary Stents Market size ($MILLION), Sales Volume and Forecasts (2022 – 2030) 9.4. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 9.4.1. Dual Therapy Stents 9.4.2. Radioactive Stents 9.4.3. Thrombectomy Stents 9.4.4. Covered Stents 9.4.5. Bioresorbable Stents 9.4.6. Biodegradable Stents 9.4.7. Hybrid Stents 9.4.8. Drug-Eluting Stents 9.4.9. Bare Metal Stents 9.4.10. Other Devices 9.5. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 9.5.1. Coronary Artery Disease 9.5.2. Peripheral Artery Disease 9.5.3. Renal Artery Stenosis 9.5.4. Others 9.6. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 9.6.1. Nitinol 9.6.2. Stainless Steel 9.6.3. Cobalt-Chromium Alloy 9.6.4. Others 9.7. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 9.7.1. Polymer-based Coated Stents 9.7.2. Non-polymer Coated Stents 9.7.3. Carbon-based Coated Stents 9.7.4. Titanium-nitride Oxide Coated Stents 9.7.5. Silicon-carbide Coated Stents 9.8. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 9.8.1. Balloon-Expandable Stents 9.8.2. Stent Grafts 9.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 9.8.4. Embolic Protection Stents 9.8.5. Self-Expandable Stents 9.9. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 9.9.1. Laser Cutting 9.9.2. 3D-Printed Stents 9.9.3. Microfabrication 9.9.4. Nanotechnology-based Stents 9.9.5. Electropolishing 9.9.6. Others 9.10. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 9.10.1. Hospitals 9.10.2. Diagnostic Centers 9.10.3. Ambulatory Surgical Centers 9.10.4. Academic and Research Institutes 9.10.5. Cardiology Center 9.11. North America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Geography 9.11.1. USA 9.11.1.1. California 9.11.1.2. Texas 9.11.1.3. Florida 9.11.1.4. Pennsylvania 9.11.1.5. Illinois 9.11.1.6. North Carolina 9.11.1.7. Rest of the U.S. 9.11.2. Canada 9.11.3. Rest of North America 10. EUROPE CORONARY STENTS MARKET ANALYSIS 10.1. Overview 10.2. Europe Coronary Stents Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 10.3. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030) 10.4. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 10.4.1. Dual Therapy Stents 10.4.2. Radioactive Stents 10.4.3. Thrombectomy Stents 10.4.4. Covered Stents 10.4.5. Bioresorbable Stents 10.4.6. Biodegradable Stents 10.4.7. Hybrid Stents 10.4.8. Drug-Eluting Stents 10.4.9. Bare Metal Stents 10.4.10. Other Devices 10.5. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 10.5.1. Coronary Artery Disease 10.5.2. Peripheral Artery Disease 10.5.3. Renal Artery Stenosis 10.5.4. Others 10.6. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 10.6.1. Nitinol 10.6.2. Stainless Steel 10.6.3. Cobalt-Chromium Alloy 10.6.4. Others 10.7. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 10.7.1. Polymer-based Coated Stents 10.7.2. Non-polymer Coated Stents 10.7.3. Carbon-based Coated Stents 10.7.4. Titanium-nitride Oxide Coated Stents 10.7.5. Silicon-carbide Coated Stents 10.8. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 10.8.1. Balloon-Expandable Stents 10.8.2. Stent Grafts 10.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 10.8.4. Embolic Protection Stents 10.8.5. Self-Expandable Stents 10.9. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 10.9.1. Laser Cutting 10.9.2. 3D-Printed Stents 10.9.3. Microfabrication 10.9.4. Nanotechnology-based Stents 10.9.5. Electropolishing 10.9.6. Others 10.10. Europe Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 10.10.1. Hospitals 10.10.2. Diagnostic Centers 10.10.3. Ambulatory Surgical Centers 10.10.4. Academic and Research Institutes 10.10.5. Cardiology Center 10.11. Europe Global Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Region 10.11.1. Germany 10.11.2. UK 10.11.3. France 10.11.4. Spain 10.11.5. Italy 10.11.6. Benelux 10.11.7. Rest of Europe 11. ASIA PACIFIC CORONARY STENTS MARKET ANALYSIS 11.1. Overview 11.2. Asia Pacific Coronary Stents Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 11.3. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030) 11.4. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 11.4.1. Dual Therapy Stents 11.4.2. Radioactive Stents 11.4.3. Thrombectomy Stents 11.4.4. Covered Stents 11.4.5. Bioresorbable Stents 11.4.6. Biodegradable Stents 11.4.7. Hybrid Stents 11.4.8. Drug-Eluting Stents 11.4.9. Bare Metal Stents 11.4.10. Other Devices 11.5. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 11.5.1. Coronary Artery Disease 11.5.2. Peripheral Artery Disease 11.5.3. Renal Artery Stenosis 11.5.4. Others 11.6. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 11.6.1. Nitinol 11.6.2. Stainless Steel 11.6.3. Cobalt-Chromium Alloy 11.6.4. Others 11.7. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 11.7.1. Polymer-based Coated Stents 11.7.2. Non-polymer Coated Stents 11.7.3. Carbon-based Coated Stents 11.7.4. Titanium-nitride Oxide Coated Stents 11.7.5. Silicon-carbide Coated Stents 11.8. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 11.8.1. Balloon-Expandable Stents 11.8.2. Stent Grafts 11.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 11.8.4. Embolic Protection Stents 11.8.5. Self-Expandable Stents 11.9. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 11.9.1. Laser Cutting 11.9.2. 3D-Printed Stents 11.9.3. Microfabrication 11.9.4. Nanotechnology-based Stents 11.9.5. Electropolishing 11.9.6. Others 11.10. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 11.10.1. Hospitals 11.10.2. Diagnostic Centers 11.10.3. Ambulatory Surgical Centers 11.10.4. Academic and Research Institutes 11.10.5. Cardiology Center 11.11. Asia Pacific Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Region 11.11.1. China 11.11.2. Japan 11.11.3. Korea 11.11.4. India 11.11.5. Australia 11.11.6. Rest of APAC 12. LATIN AMERICA CORONARY STENTS MARKET ANALYSIS 12.1. Overview 12.2. Latin America Coronary Stents Market Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 12.3. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030) 12.4. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 12.4.1. Dual Therapy Stents 12.4.2. Radioactive Stents 12.4.3. Thrombectomy Stents 12.4.4. Covered Stents 12.4.5. Bioresorbable Stents 12.4.6. Biodegradable Stents 12.4.7. Hybrid Stents 12.4.8. Drug-Eluting Stents 12.4.9. Bare Metal Stents 12.4.10. Other Devices 12.5. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 12.5.1. Coronary Artery Disease 12.5.2. Peripheral Artery Disease 12.5.3. Renal Artery Stenosis 12.5.4. Others 12.6. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 12.6.1. Nitinol 12.6.2. Stainless Steel 12.6.3. Cobalt-Chromium Alloy 12.6.4. Others 12.7. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 12.7.1. Polymer-based Coated Stents 12.7.2. Non-polymer Coated Stents 12.7.3. Carbon-based Coated Stents 12.7.4. Titanium-nitride Oxide Coated Stents 12.7.5. Silicon-carbide Coated Stents 12.8. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 12.8.1. Balloon-Expandable Stents 12.8.2. Stent Grafts 12.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 12.8.4. Embolic Protection Stents 12.8.5. Self-Expandable Stents 12.9. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 12.9.1. Laser Cutting 12.9.2. 3D-Printed Stents 12.9.3. Microfabrication 12.9.4. Nanotechnology-based Stents 12.9.5. Electropolishing 12.9.6. Others 12.10. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 12.10.1. Hospitals 12.10.2. Diagnostic Centers 12.10.3. Ambulatory Surgical Centers 12.10.4. Academic and Research Institutes 12.10.5. Cardiology Center 12.11. Latin America Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Region 12.11.1. Latin America 12.11.2. Middle East 12.11.3. Africa 13. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET ANALYSIS 13.1. Overview 13.2. Middle East and Africa Coronary Stents Market Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 13.3. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030) 13.4. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Product Type 13.4.1. Dual Therapy Stents 13.4.2. Radioactive Stents 13.4.3. Thrombectomy Stents 13.4.4. Covered Stents 13.4.5. Bioresorbable Stents 13.4.6. Biodegradable Stents 13.4.7. Hybrid Stents 13.4.8. Drug-Eluting Stents 13.4.9. Bare Metal Stents 13.4.10. Other Devices 13.5. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Application 13.5.1. Coronary Artery Disease 13.5.2. Peripheral Artery Disease 13.5.3. Renal Artery Stenosis 13.5.4. Others 13.6. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Endovascular Material 13.6.1. Nitinol 13.6.2. Stainless Steel 13.6.3. Cobalt-Chromium Alloy 13.6.4. Others 13.7. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Coating 13.7.1. Polymer-based Coated Stents 13.7.2. Non-polymer Coated Stents 13.7.3. Carbon-based Coated Stents 13.7.4. Titanium-nitride Oxide Coated Stents 13.7.5. Silicon-carbide Coated Stents 13.8. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Mode of Delivery 13.8.1. Balloon-Expandable Stents 13.8.2. Stent Grafts 13.8.3. Transcatheter Aortic Valve Replacement (TAVR) Stents 13.8.4. Embolic Protection Stents 13.8.5. Self-Expandable Stents 13.9. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Technology 13.9.1. Laser Cutting 13.9.2. 3D-Printed Stents 13.9.3. Microfabrication 13.9.4. Nanotechnology-based Stents 13.9.5. Electropolishing 13.9.6. Others 13.10. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By End-User 13.10.1. Hospitals 13.10.2. Diagnostic Centers 13.10.3. Ambulatory Surgical Centers 13.10.4. Academic and Research Institutes 13.10.5. Cardiology Center 13.11. Middle East and Africa Coronary Stents Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2030), By Region 13.11.1. Latin America 13.11.2. Middle East 13.11.3. Africa 14. COMPANY PROFILES 14.1. ABBOTT LABORATORIES 14.1.1. Company Overview 14.1.2. Company Snapshot 14.1.3. Operating business segments 14.1.4. Technique offered and Revenue from Coronary Stents Business 14.1.5. Key business performances, strategies and developments 14.2. BOSTON SCIENTIFIC CORPORATION 14.2.1. Company Overview 14.2.2. Company Snapshot 14.2.3. Operating business segments 14.2.4. Technique offered and Revenue from Coronary Stents Business 14.2.5. Key business performances, strategies and developments 14.3. MEDTRONIC PLC 14.3.1. Company Overview 14.3.2. Company Snapshot 14.3.3. Operating business segments 14.3.4. Technique offered and Revenue from Coronary Stents Business 14.3.5. Key business performances, strategies and developments 14.4. TERUMO CORPORATION 14.4.1. Company Overview 14.4.2. Company Snapshot 14.4.3. Operating business segments 14.4.4. Technique offered and Revenue from Coronary Stents Business 14.4.5. Key business performances, strategies and developments 14.5. B. BRAUN MELSUNGEN AG 14.5.1. Company Overview 14.5.2. Company Snapshot 14.5.3. Operating business segments 14.5.4. Technique offered and Revenue from Coronary Stents Business 14.5.5. Key business performances, strategies and developments 14.6. BIOSENSORS INTERNATIONAL GROUP, LTD. 14.6.1. Company Overview 14.6.2. Company Snapshot 14.6.3. Operating business segments 14.6.4. Technique offered and Revenue from Coronary Stents Business 14.6.5. Key business performances, strategies and developments 14.7. BIOTRONIK SE & CO. KG 14.7.1. Company Overview 14.7.2. Company Snapshot 14.7.3. Operating business segments 14.7.4. Technique offered and Revenue from Coronary Stents Business 14.7.5. Key business performances, strategies and developments 14.8. COOK MEDICAL INC. 14.8.1. Company Overview 14.8.2. Company Snapshot 14.8.3. Operating business segments 14.8.4. Technique offered and Revenue from Coronary Stents Business 14.8.5. Key business performances, strategies and developments 14.9. C. R. BARD, INC. (NOW PART OF B.D.) 14.9.1. Company Overview 14.9.2. Company Snapshot 14.9.3. Operating business segments 14.9.4. Technique offered and Revenue from Coronary Stents Business 14.9.5. Key business performances, strategies and developments 14.10. ENDOLOGIX INC. 14.10.1. Company Overview 14.10.2. Company Snapshot 14.10.3. Operating business segments 14.10.4. Technique offered and Revenue from Coronary Stents Business 14.10.5. Key business performances, strategies and developments 14.11. CORDIS CORPORATION (A CARDINAL HEALTH COMPANY) 14.11.1. Company Overview 14.11.2. Company Snapshot 14.11.3. Operating business segments 14.11.4. Technique offered and Revenue from Coronary Stents Business 14.11.5. Key business performances, strategies and developments 14.12. MICROPORT SCIENTIFIC CORPORATION 14.12.1. Company Overview 14.12.2. Company Snapshot 14.12.3. Operating business segments 14.12.4. Technique offered and Revenue from Coronary Stents Business 14.12.5. Key business performances, strategies and developments 14.13. W. L. GORE & ASSOCIATES, INC. 14.13.1. Company Overview 14.13.2. Company Snapshot 14.13.3. Operating business segments 14.13.4. Technique offered and Revenue from Coronary Stents Business 14.13.5. Key business performances, strategies and developments 14.14. MERIL LIFE SCIENCES PVT. LTD. 14.14.1. Company Overview 14.14.2. Company Snapshot 14.14.3. Operating business segments 14.14.4. Technique offered and Revenue from Coronary Stents Business 14.14.5. Key business performances, strategies and developments 14.15. STENTYS SA 14.15.1. Company Overview 14.15.2. Company Snapshot 14.15.3. Operating business segments 14.15.4. Technique offered and Revenue from Coronary Stents Business 14.15.5. Key business performances, strategies and developments 14.16. Other Market Players LIST OF TABLES (249 TABLES) 1. TABLE: MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 2. TABLE: MARKET FOR DUAL THERAPY STENTS, BY REGION, 2022-2030 (USD MILLION) 3. TABLE: MARKET FOR RADIOACTIVE STENTS, BY REGION, 2022-2030 (USD MILLION) 4. TABLE: MARKET FOR THROMBECTOMY STENTS, BY REGION, 2022-2030 (USD MILLION) 5. TABLE: MARKET FOR COVERED STENTS, BY REGION, 2022-2030 (USD MILLION) 6. TABLE: MARKET FOR BIORESORBABLE STENTS, BY REGION, 2022-2030 (USD MILLION) 7. TABLE: MARKET FOR BIODEGRADABLE STENTS, BY REGION, 2022-2030 (USD MILLION) 8. TABLE: MARKET FOR HYBRID STENTS, BY REGION, 2022-2030 (USD MILLION) 9. TABLE: MARKET FOR DRUG-ELUTING STENTS, BY REGION, 2022-2030 (USD MILLION) 10. TABLE: MARKET FOR BARE METAL STENTS, BY REGION, 2022-2030 (USD MILLION) 11. TABLE: MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 12. TABLE: MARKET FOR CORONARY ARTERY DISEASE BY REGION, 2022-2030 (USD MILLION) 13. TABLE: MARKET FOR PERIPHERAL ARTERY DISEASE, BY REGION, 2022-2030 (USD MILLION) 14. TABLE: MARKET FOR RENAL ARTERY STENOSIS, BY REGION, 2022-2030 (USD MILLION) 15. TABLE: MARKET FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 16. TABLE: MARKET FOR GERIATRIC, BY REGION, 2022-2030 (USD MILLION) 17. TABLE: MARKET FOR PEDIATRIC BY REGION, 2022-2030 (USD MILLION) 18. TABLE: MARKET FOR ADULT, BY REGION, 2022-2030 (USD MILLION) 19. TABLE: MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 20. TABLE: MARKET FOR NITINOL, BY REGION, 2022-2030 (USD MILLION) 21. TABLE: MARKET FOR STAINLESS STEEL, BY REGION, 2022-2030 (USD MILLION) 22. TABLE: MARKET FOR COBALT-CHROMIUM ALLOY, BY REGION, 2022-2030 (USD MILLION) 23. TABLE: MARKET FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 24. TABLE: MARKET, BY COATING, 2022-2030 (USD MILLION) 25. TABLE: MARKET FOR POLYMER-BASED COATED STENTS, BY REGION, 2022-2030 (USD MILLION) 26. TABLE: MARKET FOR NON-POLYMER COATED STENTS, BY REGION, 2022-2030 (USD MILLION) 27. TABLE: MARKET FOR CARBON-BASED COATED STENTS, BY REGION, 2022-2030 (USD MILLION) 28. TABLE: MARKET FOR TITANIUM-NITRIDE OXIDE COATED STENTS, BY REGION, 2022-2030 (USD MILLION) 29. TABLE: MARKET FOR SILICON-CARBIDE COATED STENTS, BY REGION, 2022-2030 (USD MILLION) 30. TABLE: MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 31. TABLE: MARKET FOR BALLOON-EXPANDABLE STENTS, BY REGION, 2022-2030 (USD MILLION) 32. TABLE: MARKET FOR STENT GRAFTS, BY REGION, 2022-2030 (USD MILLION) 33. TABLE: MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) STENTS, BY REGION, 2022-2030 (USD MILLION) 34. TABLE: MARKET FOR EMBOLIC PROTECTION STENTS, BY REGION, 2022-2030 (USD MILLION) 35. TABLE: MARKET FOR SELF-EXPANDABLE STENTS, BY REGION, 2022-2030 (USD MILLION) 36. TABLE: MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 37. TABLE: MARKET FOR LASER CUTTING, BY REGION, 2022-2030 (USD MILLION) 38. TABLE: MARKET FOR 3D-PRINTED STENTS, BY REGION, 2022-2030 (USD MILLION) 39. TABLE: MARKET FOR MICROFABRICATION, BY REGION, 2022-2030 (USD MILLION) 40. TABLE: MARKET FOR NANOTECHNOLOGY-BASED STENTS, BY REGION, 2022-2030 (USD MILLION) 41. TABLE: MARKET FOR ELECTROPOLISHING, BY REGION, 2022-2030 (USD MILLION) 42. TABLE: MARKET FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 43. TABLE: MARKET, BY END-USER, 2022-2030 (USD MILLION) 44. TABLE: MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION) 45. TABLE: MARKET FOR DIAGNOSTIC CENTERS BY REGION, 2022-2030 (USD MILLION) 46. TABLE: MARKET FOR AMBULATORY SURGICAL CENTERS BY REGION, 2022-2030 (USD MILLION) 47. TABLE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2030 (USD MILLION) 48. TABLE: MARKET FOR CARDIOLOGY CENTER, BY REGION, 2022-2030 (USD MILLION) 49. TABLE: MARKET, BY REGION, 2022-2030 (USD MILLION) 50. TABLE: NORTH AMERICA MARKET, BY REGION, 2022-2030 (USD MILLION) 51. TABLE: NORTH AMERICA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 52. TABLE: NORTH AMERICA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 53. TABLE: NORTH AMERICA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 54. TABLE: NORTH AMERICA MARKET, BY COATING, 2022-2030 (USD MILLION) 55. TABLE: NORTH AMERICA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 56. TABLE: NORTH AMERICA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 57. TABLE: NORTH AMERICA MARKET, BY END-USER, 2022-2030 (USD MILLION) 58. TABLE: USA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 59. TABLE: USA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 60. TABLE: USA MARKET BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 61. TABLE: USA MARKET, BY COATING, 2022-2030 (USD MILLION) 62. TABLE: USA MARKET BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 63. TABLE: USA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 64. TABLE: USA MARKET, BY END-USER, 2022-2030 (USD MILLION) 65. TABLE: CALIFORNIA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 66. TABLE: CALIFORNIA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 67. TABLE: CALIFORNIA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 68. TABLE: CALIFORNIA MARKET, BY COATING, 2022-2030 (USD MILLION) 69. TABLE: CALIFORNIA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 70. TABLE: CALIFORNIA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 71. TABLE: CALIFORNIA MARKET, BY END-USER, 2022-2030 (USD MILLION) 72. TABLE: TEXAS MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 73. TABLE: TEXAS MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 74. TABLE: TEXAS MARKET BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 75. TABLE: TEXAS MARKET, BY COATING, 2022-2030 (USD MILLION) 76. TABLE: TEXAS MARKET BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 77. TABLE: TEXAS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 78. TABLE: TEXAS MARKET, BY END-USER, 2022-2030 (USD MILLION) 79. TABLE: FLORIDA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 80. TABLE: FLORIDA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 81. TABLE: FLORIDA MARKET BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 82. TABLE: FLORIDA MARKET, BY COATING, 2022-2030 (USD MILLION) 83. TABLE: FLORIDA MARKET BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 84. TABLE: FLORIDA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 85. TABLE: FLORIDA MARKET, BY END-USER, 2022-2030 (USD MILLION) 86. TABLE: CANADA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 87. TABLE: CANADA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 88. TABLE: CANADA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 89. TABLE: CANADA MARKET, BY COATING, 2022-2030 (USD MILLION) 90. TABLE: CANADA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 91. TABLE: CANADA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 92. TABLE: CANADA MARKET, BY END-USER, 2022-2030 (USD MILLION) 93. TABLE: MEXICO MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 94. TABLE: MEXICO MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 95. TABLE: MEXICO MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 96. TABLE: MEXICO MARKET, BY COATING, 2022-2030 (USD MILLION) 97. TABLE: MEXICO MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 98. TABLE: MEXICO MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 99. TABLE: MEXICO MARKET, BY END-USER, 2022-2030 (USD MILLION) 100. TABLE: REST OF NORTH AMERICA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 101. TABLE: REST OF NORTH AMERICA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 102. TABLE: REST OF NORTH AMERICA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 103. TABLE: REST OF NORTH AMERICA MARKET, BY COATING, 2022-2030 (USD MILLION) 104. TABLE: REST OF NORTH AMERICA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 105. TABLE: REST OF NORTH AMERICA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 106. TABLE: REST OF NORTH AMERICA MARKET, BY END-USER, 2022-2030 (USD MILLION) 107. TABLE: EUROPE MARKET, BY REGION, 2022-2030 (USD MILLION) 108. TABLE: EUROPE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 109. TABLE: EUROPE MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 110. TABLE: EUROPE MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 111. TABLE: EUROPE MARKET, BY COATING, 2022-2030 (USD MILLION) 112. TABLE: EUROPE MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 113. TABLE: EUROPE MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 114. TABLE: EUROPE MARKET, BY END-USER, 2022-2030 (USD MILLION) 115. TABLE: GERMANY MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 116. TABLE: GERMANY MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 117. TABLE: GERMANY MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 118. TABLE: GERMANY MARKET, BY COATING, 2022-2030 (USD MILLION) 119. TABLE: GERMANY MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 120. TABLE: GERMANY MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 121. TABLE: GERMANY MARKET, BY END-USER, 2022-2030 (USD MILLION) 122. TABLE: FRANCE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 123. TABLE: FRANCE MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 124. TABLE: FRANCE MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 125. TABLE: FRANCE MARKET, BY COATING, 2022-2030 (USD MILLION) 126. TABLE: FRANCE MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 127. TABLE: FRANCE MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 128. TABLE: FRANCE MARKET, BY END-USER, 2022-2030 (USD MILLION) 129. TABLE: UK MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 130. TABLE: UK MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 131. TABLE: UK MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 132. TABLE: UK MARKET, BY COATING, 2022-2030 (USD MILLION) 133. TABLE: UK MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 134. TABLE: UK MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 135. TABLE: UK MARKET, BY END-USER, 2022-2030 (USD MILLION) 136. TABLE: ITALY MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 137. TABLE: ITALY MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 138. TABLE: ITALY MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 139. TABLE: ITALY MARKET, BY COATING, 2022-2030 (USD MILLION) 140. TABLE: ITALY MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 141. TABLE: ITALY MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 142. TABLE: ITALY MARKET, BY END-USER, 2022-2030 (USD MILLION) 143. TABLE: SPAIN MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 144. TABLE: SPAIN MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 145. TABLE: SPAIN MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 146. TABLE: SPAIN MARKET, BY COATING, 2022-2030 (USD MILLION) 147. TABLE: SPAIN MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 148. TABLE: SPAIN MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 149. TABLE: SPAIN MARKET, BY END-USER, 2022-2030 (USD MILLION) 150. TABLE: REST OF EUROPE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 151. TABLE: REST OF EUROPE MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 152. TABLE: REST OF EUROPE MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 153. TABLE: REST OF EUROPE MARKET, BY COATING, 2022-2030 (USD MILLION) 154. TABLE: REST OF EUROPE MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 155. TABLE: REST OF EUROPE MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 156. TABLE: REST OF EUROPE MARKET, BY END-USER, 2022-2030 (USD MILLION) 157. TABLE: ASIA PACIFIC MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 158. TABLE: ASIA PACIFIC MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 159. TABLE: ASIA PACIFIC MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 160. TABLE: ASIA PACIFIC MARKET, BY COATING, 2022-2030 (USD MILLION) 161. TABLE: ASIA PACIFIC MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 162. TABLE: ASIA PACIFIC MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 163. TABLE: ASIA PACIFIC MARKET, BY END-USER, 2022-2030 (USD MILLION) 164. TABLE: CHINA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 165. TABLE: CHINA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 166. TABLE: CHINA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 167. TABLE: CHINA MARKET, BY COATING, 2022-2030 (USD MILLION) 168. TABLE: CHINA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 169. TABLE: CHINA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 170. TABLE: CHINA MARKET, BY END-USER, 2022-2030 (USD MILLION) 171. TABLE: INDIA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 172. TABLE: INDIA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 173. TABLE: INDIA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 174. TABLE: INDIA MARKET, BY COATING, 2022-2030 (USD MILLION) 175. TABLE: INDIA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 176. TABLE: INDIA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 177. TABLE: INDIA MARKET, BY END-USER, 2022-2030 (USD MILLION) 178. TABLE: JAPAN MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 179. TABLE: JAPAN MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 180. TABLE: JAPAN MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 181. TABLE: JAPAN MARKET, BY COATING, 2022-2030 (USD MILLION) 182. TABLE: JAPAN MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 183. TABLE: JAPAN MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 184. TABLE: JAPAN MARKET, BY END-USER, 2022-2030 (USD MILLION) 185. TABLE: KOREA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 186. TABLE: KOREA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 187. TABLE: KOREA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 188. TABLE: KOREA MARKET, BY COATING, 2022-2030 (USD MILLION) 189. TABLE: KOREA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 190. TABLE: KOREA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 191. TABLE: KOREA MARKET, BY END-USER, 2022-2030 (USD MILLION) 192. TABLE: AUSTRALIA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 193. TABLE: AUSTRALIA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 194. TABLE: AUSTRALIA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 195. TABLE: AUSTRALIA MARKET, BY COATING, 2022-2030 (USD MILLION) 196. TABLE: AUSTRALIA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 197. TABLE: AUSTRALIA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 198. TABLE: AUSTRALIA MARKET, BY END-USER, 2022-2030 (USD MILLION) 199. TABLE: REST OF ASIA PACIFIC MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 200. TABLE: REST OF ASIA PACIFIC MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 201. TABLE: REST OF ASIA PACIFIC MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 202. TABLE: REST OF ASIA PACIFIC MARKET, BY COATING, 2022-2030 (USD MILLION) 203. TABLE: REST OF ASIA PACIFIC MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 204. TABLE: REST OF ASIA PACIFIC MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 205. TABLE: REST OF ASIA PACIFIC MARKET, BY END-USER, 2022-2030 (USD MILLION) 206. TABLE: LATIN AMERICA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 207. TABLE: LATIN AMERICA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 208. TABLE: LATIN AMERICA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 209. TABLE: LATIN AMERICA MARKET, BY COATING, 2022-2030 (USD MILLION) 210. TABLE: LATIN AMERICA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 211. TABLE: LATIN AMERICA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 212. TABLE: LATIN AMERICA MARKET, BY END-USER, 2022-2030 (USD MILLION) 213. TABLE: MIDDLE EAST AND AFRICA MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION) 214. TABLE: MIDDLE EAST AND AFRICA MARKET, BY ENDOVASCULAR APPLICATION, 2022-2030 (USD MILLION) 215. TABLE: MIDDLE EAST AND AFRICA MARKET, BY ENDOVASCULAR MATERIAL, 2022-2030 (USD MILLION) 216. TABLE: MIDDLE EAST AND AFRICA MARKET, BY COATING, 2022-2030 (USD MILLION) 217. TABLE: MIDDLE EAST AND AFRICA MARKET, BY MODE OF DELIVERY, 2022-2030 (USD MILLION) 218. TABLE: MIDDLE EAST AND AFRICA MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 219. TABLE: MIDDLE EAST AND AFRICA MARKET, BY END-USER, 2022-2030 (USD MILLION) 220. TABLE: ABBOTT LABORATORIES. COMPANY SNAPSHOT 221. TABLE: ABBOTT LABORATORIES. OPERATING SEGMENTS 222. TABLE: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 223. TABLE: BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS 224. TABLE: MEDTRONIC PLC: COMPANY SNAPSHOT 225. TABLE: MEDTRONIC PLC: OPERATING SEGMENTS 226. TABLE: TERUMO CORPORATION: COMPANY SNAPSHOT 227. TABLE: TERUMO CORPORATION: OPERATING SEGMENTS 228. TABLE: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 229. TABLE: B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS 230. TABLE: BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY SNAPSHOT 231. TABLE: BIOSENSORS INTERNATIONAL GROUP, LTD.: OPERATING SEGMENTS 232. TABLE: BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT 233. TABLE: BIOTRONIK SE & CO. KG: OPERATING SEGMENTS 234. TABLE: COOK MEDICAL INC.: COMPANY SNAPSHOT 235. TABLE: COOK MEDICAL INC.: OPERATING SEGMENTS 236. TABLE: C. R. BARD, INC. (NOW PART OF B.D.): COMPANY SNAPSHOT 237. TABLE: C. R. BARD, INC. (NOW PART OF B.D.): OPERATING SEGMENTS 238. TABLE: ENDOLOGIX INC.: COMPANY SNAPSHOT 239. TABLE: ENDOLOGIX INC.: OPERATING SEGMENTS 240. TABLE: CORDIS CORPORATION (A CARDINAL HEALTH COMPANY): COMPANY SNAPSHOT 241. TABLE: CORDIS CORPORATION (A CARDINAL HEALTH COMPANY): OPERATING SEGMENTS 242. TABLE: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 243. TABLE: MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS 244. TABLE: W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT 245. TABLE: W. L. GORE & ASSOCIATES, INC.: OPERATING SEGMENTS 246. TABLE: MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT 247. TABLE: MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS 248. TABLE: STENTYS SA: COMPANY SNAPSHOT 249. TABLE: STENTYS SA: OPERATING SEGMENTS LIST OF FIGURES (44 FIGURES) 1. Figure: Market: Research Methodology Steps 2. Figure: Research Design 3. Figure: Breakdown of Primaries: Market 4. Figure: Research Methodology: Hypothesis Building 5. Figure: Market: Technique and Service-Based Estimation 6. Figure: Top 15 Companies with Highest No. Of Patent in Last 9 Years 7. Figure: Growth Strategies Adopted By the Key Players 8. Figure: Top 15 Companies with Highest No. Of Patent in Last 9 Years 9. Figure: Growth Strategies Adopted By the Key Players 10. Figure: No. of Patents Granted Per Year, 2022–2030 11. Figure: Data Triangulation Methodology 12. Figure: Dominating Market Share, By Product Type, 2022 vs. 2030 (USD MILLION) 13. Figure: Dominating Market Share, By Endovascular Application, 2022 vs. 2030 (USD MILLION) 14. Figure: Dominating Market Share, By Endovascular Material, 2022 vs. 2030 (USD MILLION) 15. Figure: Dominating Market Share, By Coating, 2022 vs. 2030 (USD MILLION) 16. Figure: Dominating Market Share, By Mode of Delivery, 2022 vs. 2030 (USD MILLION) 17. Figure: Dominating Market Share, By Technology, 2022 vs. 2030 (USD MILLION) 18. Figure: Dominating Market Share, By End-User, 2022 vs. 2030 (USD MILLION) 19. Figure: Geographical Snapshot of the Market 20. Figure: Nitinol to Witness Higher CAGR in the Market for Endovascular Material Segment during the Forecast Period. 21. Figure: North America Accounted for the Largest Share of the Market, By Regional Basis, in 2022 22. Figure: Market: Drivers, Restraints, Opportunities, and Challenges 23. Figure: North America: Market Snapshot 24. Figure: Asia Pacific: Market Snapshot 25. Figure: Europe: Market Snapshot 26. Figure: Latin America: Market Snapshot 27. Figure: Middle East and Africa: Market Snapshot 28. Figure: Vendor Dive: Evaluation Overview 29. Figure: Global Coronary Stents: Competitive Benchmarking 30. Figure: Abbott Laboratories. Financial Overview (2022-2030) 31. Figure: Boston Scientific Corporation: Financial Overview (2022-2030) 32. Figure: Medtronic plc: Financial Overview (2022-2030) 33. Figure: Terumo Corporation: Financial Overview (2022-2030) 34. Figure: B. Braun Melsungen AG: Financial Overview (2022-2030) 35. Figure: Biosensors International Group, Ltd.: Financial Overview (2022-2030) 36. Figure: BIOTRONIK SE & Co. KG: Financial Overview (2022-2030) 37. Figure: Cook Medical Inc.: Financial Overview (2022-2030) 38. Figure: C. R. Bard, Inc. (now part of B.D.): Financial Overview (2022-2030) 39. Figure: Endologix Inc.: Financial Overview (2022-2030) 40. Figure: Cordis Corporation (a Cardinal Health company): Financial Overview (2022-2030) 41. Figure: MicroPort Scientific Corporation: Financial Overview (2022-2030) 42. Figure: W. L. Gore & Associates, Inc.: Financial Overview (2022-2030) 43. Figure: Meril Life Sciences Pvt. Ltd.: Financial Overview (2022-2030) 44. Figure: STENTYS SA: Financial Overview (2022-2030)